Search Result For "targeted cancer therapy"
Brand No available data!
Generic No available data
Generic Name : Panitumumab
Indication : Treatment of adult patients w/ wild-type RAS metastatic colorectal cancer (mCRC): 1st-line in combination w/ FOLFOX or FOLFIRI; 2nd-line in combination w/ FOLFIRI for patients who have received 1st-li...
Manufacturer : Amgen
Generic Name : Bortezomib
Indication : As monotherapy or in combination w/ pegylated liposomal doxorubicin or dexamethasone for adult patients w/ progressive multiple myeloma who have received at least 1 prior therapy & who have alread...
Manufacturer : Janssen
Generic Name : Venetoclax
Indication : Treatment of adult patients w/ chronic lymphocytic leukemia (CLL). In combination w/ azacitidine, or decitabine, or low-dose cytarabine for the treatment of newly diagnosed AML in adults ≥75 yr, or...
Manufacturer : AbbVie
Generic Name : Abemaciclib
Indication : In combination w/ endocrine therapy for adjuvant treatment of adult patients w/ hormone receptor (HR) +ve, human epidermal growth factor receptor 2 (HER2) -ve, node +ve early breast cancer at high ris...
Manufacturer : Eli Lilly
Distributor : Zuellig
Generic Name : Larotrectinib
Indication : Treatment of adult & ped patients w/ solid tumours that have a Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusion w/o a known acquired resistance mutation, are metastatic or where surgical r...
Manufacturer : Bayer
Distributor : Zuellig
Generic Name : Pazopanib
Indication : 1st-line treatment of advanced renal cell carcinoma in adults & for patients who received prior cytokine therapy for advanced disease. Treatment of selective subtypes of advanced soft tissue sarco...
Manufacturer : Novartis
Distributor : DKSH / Four Star
Generic Name : belzutifan
Indication : Von Hippel-Lindau disease in adults who require therapy for associated renal cell carcinoma, CNS hemangioblastomas, or pancreatic neuroendocrine tumors, not requiring immediate surgery.
Manufacturer : MSD
Distributor : Zuellig
Generic Name : Gilteritinib
Indication : Monotherapy for the treatment of adult patients who have relapsed or refractory AML w/ FMS-like tyrosine kinase 3 (FLT3) mutation.
Manufacturer : Astellas
Related Diseases

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in Find Drug Company.
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in Find Drug Company.
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in